Title Collaboration Type HHS Participating Agencies NIH Participating Institutes, Centers, and Offices Description
Multi-Agency Tissue Engineering Science (MATES) Interagency Working Group Committee, Work group, Advisory group, or Task Force ACL, CMS, FDA NIBIB, NCI, NHLBI, NIA, NIAMS, NICHD, NIDCD, NIDCR, NINDS The Multi-Agency Tissue Engineering Science (MATES) Interagency Working Group (IWG), originally organized under the auspices of the Subcommittee on Biotechnology of the National Science and Technology Council (NSTC), was established in 2000 to provide a forum for federal agencies involved in tissue science and engineering to stay informed of each other’s activities and coordinate research efforts. Its five-year plan was renewed in 2002 and new Terms of Reference were introduced in 2007. Since early 2009, the MATES group has worked independently of NSTC but is in the process of being charted under the NSTC''s Subcommittee on Technology to reflect an emerging focus on translation. This process is ongoing as of December 2016. . The principal purpose of the MATES IWG is to provide a platform across which the many member agencies can interact and exchange information on tissue engineering efficiently and effectively. The group played a role in responded to a GAO review of regenerative medicine in 2015. The MATES IWG regularly organizes and co-chairs workshops at the annual premier meeting in the field, the Tissue Engineering and Regenerative Medicine International Society (TERMIS), held this past year December 11-14, 2016.
Multinational Influenza Seasonal Mortality Study (MISMS) Research Research Initiative FDA, OS FIC, NHLBI, NIAID, NLM The Multinational Influenza Seasonal Mortality Study (MISMS) was originally initiated to analyze national and global mortality patterns associated with influenza virus circulation. The focus of MISMS has since expanded to evaluate the interaction between the epidemiology, ecology, and evolutionary dynamics of influenza and other rapidly transmissible respiratory viruses, including natural selection, reassortment, migration, and antigenic change. Multinational and bilateral collaborations developed by MISMS collect, analyze, and disseminate research findings through scientific publications, training workshops, and communication tools for investigators and decision-makers. Our research findings inform numerous national governments, multilateral organizations, and research stakeholders on interventions for both pandemic and seasonal influenza. To date, data have been acquired from more than 40 countries (representing ~3.2 billion people), resulting in over 220 publications.
Muscular Dystrophy Coordinating Committee (MDCC) Committee, Work group, Advisory group, or Task Force ACL, CDC, FDA, HRSA NINDS, NHLBI, NIAMS, NICHD This Committee coordinates activities across NIH and with other Federal health programs and activities relevant to the various forms of muscular dystrophy.
My Family Health Portrait Resource Development CDC, HRSA, OSG NHGRI, NCI, NICHD, NLM My Family Health Portrait (MFHP) is a web-based tool from NHGRI and the U.S. Surgeon General’s Family History Initiative that helps individuals track their family health history. Using any computer, an Internet connection and an up-to-date Web browser, individuals add health information to build a drawing of their family tree and a chart of their family health history while exploring disease calculators. The tool is designed to keep all data on the client side to maximize privacy using HTML, CSS, and client-side JavaScript as its principal platforms. Users interact with the tool in a browser to build family health history generating an XML data file (HL7v3 standard) that users store locally or in the cloud. Both the family tree and the chart can be printed and shared with family members and an individual’s doctor.
Naloxone Workgroup Committee, Work group, Advisory group, or Task Force CDC, FDA NIDA The goal of this Workgroup is to discuss ways to implement the use of naloxone as emergency treatment for opioid overdose.
Nanomaterial Registry Resource Development CDC, FDA NCI, NIBIB, NIEHS The Nanomaterial Registry is an authoritative, fully curated resource available to the public that archives research data on nanomaterials and their biological and environmental implications.
Nanotechnology Characterization Laboratory Research Initiative FDA NCI, NIEHS The Nanotechnology Characterization Laboratory (NCL) performs and standardizes the preclinical characterization of nanomaterials intended for cancer therapeutics and diagnostics developed by researchers from academia, government, and industry. The NCL serves as a national resource and knowledge base for cancer researchers and facilitates the development and translation of nanoscale particles and devices for clinical applications.
National Academies of Sciences Issues in Organ Donor Intervention Research Study Other HRSA NHLBI, NIAID, NIDDK The Committee on Issues in Organ Donor Intervention Research is examining the ethical, policy, regulatory, and operational issues relevant to the conduct of research involving deceased organ donors (for purposes of the study, the concept excludes interventional research preceding declaration of death by neurologic or cardiopulmonary criteria among potential organ donors). The committee will examine the gaps, barriers, and opportunities for clinical research involving deceased donors that aims to increase the quality and quantity of donated organs available for transplantation, with particular attention to interventions administered to the donor and thus potentially affecting all of the donor''s organs. Specifically, the report will delineate the issues pertinent to organ donor intervention research and make recommendations to maximize public and professional trust in the organ donation process and ethical conduct of organ donor intervention research.
National Academy of Sciences "Investing in Young Children Globally" Other CDC NICHD, FIC, NIMH The NAS forum on "Investing in Young Children Globally" sponsors conferences, supports discussion papers, and engenders discussion among NAS/NAM members, federal partners, and international experts on children''s health and well being around the world. For example, a March 2016 meeting of the forum brought together two communities—early childhood development and peacebuilding—to promote knowledge exchange and identification of opportunities to leverage investments in early childhood development to promote peace. USAID, the World Bank, CDC, and ASPE along with NIH support this forum.
National Action Alliance for Suicide Prevention (NAASP) Committee, Work group, Advisory group, or Task Force ACL, CDC, HRSA, IHS, OS, OSG, SAMHSA NIMH, NIAAA, NIDA, OD/DPCPSI/OBSSR, OD/DPCPSI/ODP Founded in September 2010, the NAASP is a public-private partnership designed to advance the National Strategy for Suicide Prevention in the United States. The NAASP''s Research Priority Task Force (RPTF) is charged with developing a process to prioritize suicide prevention research efforts and consider ways to integrate science and service to ensure that suicide deaths decrease significantly within the next decade. The RPTF released the Nation''s first suicide research agenda, “A Prioritized Research Agenda for Suicide Prevention: An Action Plan to Save Lives.” The research agenda includes an overarching goal to advance suicide prevention research more rapidly, seeking ways to reduce suicide deaths and attempts by 20% in five years and by 40% or greater in ten years. In 2015, the RPTF produced the "U.S. National Suicide Prevention Research Efforts: 2008-2013 Portfolio Analyses." The analyses revealed that investments in suicide research are severely lagging, but there is a growing knowledge base of intervention research. In 2016, the National Institutes of Health, Office of Disease Prevention supported the “Pathways to Prevention Workshop, Advancing Research to Prevent Youth Suicide in 2016,” which further refined methodological challenges and data linkage needs relevant to multiple NIH Institutes. The National Institute of Mental Health (NIMH) developed a request for information relevant to this workshop, and a federal partners meeting in the spring of 2017 will consider additional actions in response to the workshop recommendations.